Business · 25/06/2020

FDA Announces Final Guidance for Developing Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

The FDA is releasing a final guidance document to help pharmaceutical companies develop effective treatments for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, based on feedback from industry stakeholders and current medical recommendations.